We are live on ! Find out more
TI

Turner Investments Portfolio holdings

AUM $134K
1-Year Est. Return 49.03%
This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
–
AUM
$248M
AUM Growth
-$54.7M
Cap. Flow
-$53.1M
Cap. Flow %
-21.45%
Top 10 Hldgs %
14.37%
Holding
315
New
136
Increased
18
Reduced
93
Closed
58

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$3.08M
2
URI icon
United Rentals
URI
+$3.05M
3
HDS
HD Supply Holdings, Inc.
HDS
+$2.72M
4
XYZ
Block Inc
XYZ
+$2.61M
5
SBAC icon
SBA Communications
SBAC
+$2.46M

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$5.27M
2
NXPI icon
NXP Semiconductors
NXPI
+$4.94M
3
ACHN
Achillion Pharmaceuticals
ACHN
+$4.67M
4
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$4.24M
5
ARMK icon
Aramark
ARMK
+$4.09M

Sector Composition

Rank Sector Weight
1 Healthcare 24.81%
2 Technology 18.88%
3 Industrials 12.19%
4 Consumer Discretionary 11.96%
5 Financials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XEC
301
DELISTED
CIMAREX ENERGY CO
XEC
– –
-2,320
Closed -$312K
PFPT
302
DELISTED
Proofpoint, Inc.
PFPT
– –
-37,910
Closed -$2.84M
GNMK
303
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-65,000
Closed -$767K
HZNP
304
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-19,340
Closed -$351K
ELLI
305
DELISTED
Ellie Mae Inc
ELLI
– –
-29,500
Closed -$3.11M
MZOR
306
DELISTED
Mazor Robotics Ltd.
MZOR
– –
-40,220
Closed -$1.04M
NVIV
307
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
– –
-5
Closed -$700K
JUNO
308
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-27,670
Closed -$830K
OCRX
309
DELISTED
Ocera Therapeutics, Inc.
OCRX
– –
-134,419
Closed -$355K
KITE
310
DELISTED
Kite Pharma, Inc.
KITE
– –
-14,230
Closed -$795K
UTEK
311
DELISTED
Ultratech Inc.
UTEK
– –
-56,000
Closed -$1.29M
STJ
312
DELISTED
St Jude Medical
STJ
– –
-10,670
Closed -$851K
EFII
313
DELISTED
Electronics for Imaging
EFII
– –
-63,000
Closed -$3.08M
RPTP
314
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
– –
-55,540
Closed -$498K
DOC
315
DELISTED
PHYSICIANS REALTY TRUST
DOC
– –
-35,000
Closed -$754K
9 10 11 12
13

Similar funds

IP
InvenTrust Properties Downers Grove, Illinois $1.08M AUM 0.39% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return
PAM
Prudence Asset Management Hong Kong $3.65M AUM 36.79% 1-Year Est. Return
CCM
Catalus Capital Management Greenwich, Connecticut $6.09M AUM 3.76% 1-Year Est. Return
GA
Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return
IPLA
Ice Pond Lane Advisers New York $7.38M AUM 1.66% 1-Year Est. Return
LRM
Lime Rock Management Westport, Connecticut $7.54M AUM 22.09% 1-Year Est. Return
HC
Highstar Capital New York $8.59M AUM 3.82% 1-Year Est. Return

Turner Investments's Q4 2016 Portfolio in Review

As of Q4 2016, Turner Investments held 315 positions worth $248M, down 18% from $302M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Turner Investments withdrew a net $53.1M in Q4 2016, closing 58 positions and reducing 93 holdings. Its most notable exit was Aramark, an estimated $4.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Turner Investments opened a new position in Idexx Laboratories worth $3.17M.

  • Turner Investments's largest Q4 2016 buy was Idexx Laboratories: 27,000 shares worth $3.17M.
  • Turner Investments added most to bluebird bio in Q4 2016, an estimated $1.26M increase.
  • Turner Investments's biggest Q4 2016 reduction was Paramount Global Class B, cutting an estimated $5.27M.
  • Turner Investments fully exited Aramark in Q4 2016, selling an estimated $4.09M.
  • Turner Investments's ten largest holdings make up 14% of its $248M portfolio in Q4 2016.
  • Turner Investments opened 136 new positions and closed 58 in Q4 2016.
  • Turner Investments's portfolio value fell 18% quarter-over-quarter to $248M.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.